Parallax Volatility Advisers’s Medifast MED Stock Holding History

Parallax Volatility Advisers’s Portfolio MED Stock Details MED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-1,085	Closed	-$230K	–	3331
2021 Q1	$230K	Buy	+1,085	New	+$260K	﹤0.01%	2616
2018 Q4	–	Sell	-25	Closed	-$6K	–	3530
2018 Q3	$6K	Sell	25 -46	-65%	-$9.33K	﹤0.01%	2295
2018 Q2	$11K	Buy	+71	New	+$9.08K	﹤0.01%	1743
2018 Q1	–	Sell	-1,596	Closed	-$111K	–	3457
2017 Q4	$111K	Buy	+1,596	New	+$106K	﹤0.01%	2744
2017 Q2	–	Sell	-285	Closed	-$13K	–	3267
2017 Q1	$13K	Buy	+285	New	+$12.3K	﹤0.01%	3109
2015 Q2	–	Sell	-576	Closed	-$17K	–	4421
2015 Q1	$17K	Buy	+576	New	+$18.3K	﹤0.01%	3689
2014 Q4	–	Sell	-1,637	Closed	-$51K	–	5529
2014 Q3	$54K	Buy	+1,637	New	+$50.2K	﹤0.01%	3266
2014 Q1	–	Sell	-409	Closed	-$11K	–	3580
2013 Q4	$11K	Sell	409 -1,662	-80%	-$42.6K	﹤0.01%	2930
2013 Q3	$56K	Buy	+2,071	New	+$55.4K	﹤0.01%	1757

Other funds holding MED

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Pacer Advisors Malvern, Pennsylvania $39.3B AUM 27.96% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Parallax Volatility Advisers's MED Position: Q2 2021 in Review

Parallax Volatility Advisers sold out of Medifast (MED) in Q2 2021, closing a stake of 1,085 shares — an estimated $230K sold.

Parallax Volatility Advisers first reported a position in MED in Q3 2013 and held it in 9 quarters. The position peaked at $230K in Q1 2021. 301 funds tracked by Wall St. Rank hold MED as of Q2 2021.

Parallax Volatility Advisers reported no remaining Medifast position as of Q2 2021 after selling out during the quarter.
Parallax Volatility Advisers sold 1,085 Medifast shares in Q2 2021, an estimated $230K.
Parallax Volatility Advisers first reported a position in Medifast in Q3 2013 and held it in 9 quarters.
Parallax Volatility Advisers's Medifast position peaked at $230K in Q1 2021.
301 funds tracked by Wall St. Rank held Medifast as of Q2 2021.

Based on Parallax Volatility Advisers's 13F filing for Q2 2021, filed 16 Aug 2021.